欧洲与美国肾脏替代治疗流行病学比较:2021年ERA登记与美国USRDS数据
该研究基于ERA登记和USRDS 2021年数据,比较欧洲与美国肾脏替代治疗(KRT)的发病率、患病率、肾移植率及死亡率。结果显示美国KRT发病率、患病率和死亡率均显著高于欧洲,尽管美国肾移植率更高,但现患患者中带功能移植物比例却低于欧洲。
要点
- 美国KRT发病率(409.7 pmp)近欧洲(144.4 pmp)的3倍。
- 美国KRT患病率(2436.1 pmp)为欧洲(1187.8 pmp)的2倍。
- 美国KRT患者死亡率(157.3/1000患者年)较欧洲(98.7/1000患者年)高1.6倍。
核心结论
- 美国KRT发病率、患病率和死亡率均远高于欧洲。
- 尽管美国肾移植率更高,但现患患者中带功能移植物比例低于欧洲。
研究设计与样本
- 比较性观察研究,数据来源于ERA登记和USRDS 2021年年度报告。
- 欧洲数据包括提供个体患者数据的国家和区域肾脏登记,并汇总所有参与欧洲国家进行分析。
主要发现
- 2021年美国KRT发病率为409.7 pmp,欧洲为144.4 pmp。
- 起始治疗模式分布相似:欧洲HD 82%、PD 14%、抢先移植4%;美国HD 84%、PD 13%、抢先移植3%。
- 美国KRT患病率为2436.1 pmp,欧洲为1187.8 pmp。
- 欧洲现患患者中47%带功能移植物,美国为32%。
- 美国肾移植数量为77.0 pmp,欧洲为41.6 pmp;美国KRT患者死亡率为157.3/1000患者年,欧洲为98.7/1000患者年。
临床怎么用
- 提示两国在KRT需求、预后及移植覆盖方面存在显著差异,可指导医疗资源配置和跨区域比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This paper compares the most recent data on the incidence and prevalence of kidney replacement therapy (KRT), kidney transplantation rates, and mortality on KRT from Europe to those from the United States (US), including comparisons of treatment modalities (haemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KTx)). METHODS: Data were derived from the annual reports of the European Renal Association (ERA) Registry and the United States Renal Data System (USRDS). The European data include information from national and regional renal registries providing the ERA Registry with individual patient data. Additional analyses were performed to present results for all participating European countries together. RESULTS: In 2021, the KRT incidence in the US (409.7 per million population (pmp)) was almost 3-fold higher than in Europe (144.4 pmp). Despite the substantial difference in KRT incidence, approximately the same proportion of patients initiated HD (Europe: 82%, US: 84%), PD (14%; 13%, respectively), or underwent pre-emptive KTx (4%; 3%, respectively). The KRT prevalence in the US (2436.1 pmp) was 2-fold higher than in Europe (1187.8 pmp). Within Europe, approximately half of all prevalent patients were living with a functioning graft (47%), while in the US, this was one third (32%). The number of kidney transplantations performed was almost twice as high in the US (77.0 pmp) compared to Europe (41.6 pmp). The mortality of patients receiving KRT was 1.6-fold higher in the US (157.3 per 1000 patient years) compared to Europe (98.7 per 1000 patient years). CONCLUSIONS: The US had a much higher KRT incidence, prevalence, and mortality compared to Europe, and despite a higher kidney transplantation rate, a lower proportion of prevalent patients with a functioning graft.
引用
- Stel VS, Boenink R, Astley ME, et al. A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS. Nephrol Dial Transplant. 2024. PMID: 38439701. doi:10.1093/ndt/gfae040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。